MAM
AUPH icon

Martingale Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Martingale Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.79M Buy
+105,640
New +$1.69M 0.04% 412
2025
Q2 		– Sell
-12,252
Closed -$98.5K – 786
2025
Q1 		$98.5K Buy
+12,252
New +$99.3K ﹤0.01% 760

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Martingale Asset Management's AUPH Position: Q2 2026 in Review

Martingale Asset Management opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 105,640 shares worth $1.79M. The stake represents 0.04% of the portfolio and ranks #412 among its holdings. This is a return to the name: Martingale Asset Management previously reported a position in AUPH as recently as Q1 2025.

Martingale Asset Management first reported a position in AUPH in Q1 2025 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Martingale Asset Management held 105,640 shares of Aurinia Pharmaceuticals worth $1.79M as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Martingale Asset Management position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.04% of Martingale Asset Management's portfolio in Q2 2026, its #412 holding.
  • Martingale Asset Management first reported a position in Aurinia Pharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.